Fig. 1 · Structure
Documents & Downloads
GSK 625433
HCV Inhibitor
GSK 625433 is a selective inhibitor targeting the hepatitis C virus (HCV), functioning primarily through the disruption of viral replication. This compound has demonstrated significant antiviral activity, making it a valuable tool for research focused on the development of HCV therapeutics. GSK 625433 can be utilized in studies investigating the efficacy of antiviral strategies and the mechanisms underlying HCV infection.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 885264-71-1 |
| Applications | HCV Inhibitor |
| Formula | C26H32N4O5S |
| Molecular Weight | 512.62 |
| SMILES | OC([C@]1(N([C@@H](C2=NC=CS2)[C@H](C1)COC)C(C3=CC(OC)=C(C=C3)C(C)(C)C)=O)CN4C=CC=N4)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.